fluorodeoxyglucose f18 has been researched along with Alveolitis, Fibrosing in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (7.69) | 18.2507 |
2000's | 8 (30.77) | 29.6817 |
2010's | 14 (53.85) | 24.3611 |
2020's | 2 (7.69) | 2.80 |
Authors | Studies |
---|---|
Beziere, N; Gawaz, M; Gonzalez-Menendez, I; Isser, S; Maurer, A; Pichler, BJ; Quintanilla-Martinez, L; Reischl, G; Schaller, M | 1 |
Beyhan Sagmen, S; Comert, S; Doğan, C; Fidan, A; Kıral, N; Küçüköz Uzun, A; Torun Parmaksız, E; Turan Erkek, E; Yılmaz Haksal, Ç; Yılmaz, G | 1 |
Culver, DA; Judson, MA | 1 |
Choi, EK; Kim, SJ; Kim, YK; Park, HL; Yoo, IR | 1 |
El-Chemaly, S; Gahl, WA; Gochuico, BR; Malide, D; Moss, J; Nathan, SD; Rosas, IO; Yao, J | 1 |
Batra, S; Bhargava, R; Gupta, S; Vaid, AK | 1 |
De Jong, PA; De Raedt, N; Dupont, LJ; Gheysens, O; Ruttens, D; Van Raemdonck, DE; Vanaudenaerde, BM; Vandermeulen, E; Verleden, GM; Verleden, SE; Vos, R; Yserbyt, J | 1 |
Bondue, B; De Vuyst, P; Doumont, G; Egrise, D; Goldman, S; Huaux, F; Lacroix, S; Parmentier, M; Rorive, S; Sauvage, S; Sherer, F; Van Simaeys, G; Vosters, O; Yakoub, Y | 1 |
Nunes, H; Silva, M; Sverzellati, N; Valeyre, D | 1 |
Chen, DL; Goo, JM; Schiebler, ML; van Beek, EJR | 1 |
Brillet, PY; Fain, O; Jacquelin, V; Mekinian, A; Nunes, H; Soussan, M; Valeyre, D | 1 |
Berovic, M; Booth, H; Dickson, JC; Ell, PJ; Endozo, R; Groves, AM; Kayani, I; Menezes, LJ; Screaton, NJ; Win, T | 1 |
Battah, S; Brown, LK; Crooks, L; Hartshorne, M; Richards, A; Wu, C | 1 |
Dahele, M; Lagerwaard, F; Palma, D; Senan, S; Slotman, B | 1 |
Choi, C; Kim, MA; Lee, JC | 1 |
Drent, M; Mostard, RL; Nelemans, PJ; van Kroonenburgh, MJ; Verschakelen, JA; Vöö, S; Wijnen, PA | 1 |
Hamamoto, Y; Kajihara, M; Kataoka, M; Mochizuki, T; Nakajima, N; Ochi, T; Sakai, S; Sugawara, Y; Takahashi, T; Teramoto, N; Yamashita, M | 1 |
Bandoh, S; Fujita, J; Ishida, T; Ishii, T; Kubo, A; Nishiyama, Y; Tojo, Y; Ueda, Y; Yamamoto, Y | 1 |
Kennedy, M; O'Connell, M | 1 |
Lowe, JE; Lyburn, ID; Wong, WL | 1 |
Hirashima, T; Iwasaki, T; Kawahara, K; Kawase, I; Kobayashi, M; Matsui, K; Sasada, S; Takimoto, T; Yamadori, T | 1 |
Brown, CV; Khonsary, SA; Mandelkern, M; Meissner, HH; Santiago, SM; Soo Hoo, GW | 1 |
Martinez, S; McAdams, HP; Youens, KE | 1 |
Goodman, PC; Harris, LK; Hoffman, JM; Lowe, VJ; Paine, SS; Patz, EF | 1 |
Boobis, AR; Haslett, C; Jones, HA; Krausz, T; Schofield, JB | 1 |
Beggs, AD; Hain, SF | 1 |
3 review(s) available for fluorodeoxyglucose f18 and Alveolitis, Fibrosing
Article | Year |
---|---|
New advances in the management of pulmonary sarcoidosis.
Topics: Biomarkers; Bronchoscopy; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Incidence; Lung; Positron-Emission Tomography; Prognosis; Pulmonary Fibrosis; Sarcoidosis, Pulmonary; Treatment Outcome | 2019 |
Imaging of Sarcoidosis.
Topics: Fluorodeoxyglucose F18; Gallium; Granuloma; Heart; Humans; Lung; Magnetic Resonance Imaging; Multidetector Computed Tomography; Prognosis; Pulmonary Fibrosis; Radiography, Thoracic; Radionuclide Imaging; Radiopharmaceuticals; Sarcoidosis | 2015 |
PET imaging approaches for inflammatory lung diseases: Current concepts and future directions.
Topics: Asthma; Fluorodeoxyglucose F18; Humans; Peptides; Pneumonia; Polyethylene Glycols; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Radiopharmaceuticals | 2017 |
23 other study(ies) available for fluorodeoxyglucose f18 and Alveolitis, Fibrosing
Article | Year |
---|---|
Radiolabeled GPVI-Fc for PET Imaging of Multiple Extracellular Matrix Fibers: A New Look into Pulmonary Fibrosis Progression.
Topics: Animals; Extracellular Matrix; Fibrosis; Fluorodeoxyglucose F18; Mice; Positron-Emission Tomography; Pulmonary Fibrosis | 2023 |
Can We Predict Bleomycin Toxicity with PET-CT?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Pulmonary Fibrosis; Vinblastine | 2019 |
The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Pneumoconiosis; Positron Emission Tomography Computed Tomography; Pulmonary Fibrosis; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2020 |
Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization.
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hermanski-Pudlak Syndrome; Humans; Inflammation; Male; Microscopy, Confocal; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals | 2013 |
Lungs on fire.
Topics: Antibiotics, Antineoplastic; Bleomycin; Fatal Outcome; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals | 2013 |
Pirfenidone: a potential new therapy for restrictive allograft syndrome?
Topics: Allografts; Anti-Inflammatory Agents, Non-Steroidal; Emphysema; Fluorodeoxyglucose F18; Humans; Lung Transplantation; Male; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Pulmonary Fibrosis; Pyridones; Radiopharmaceuticals; Syndrome; Tumor Necrosis Factor-alpha | 2013 |
PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
Topics: Animals; Biological Transport; Bleomycin; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fibrosis; Fluorodeoxyglucose F18; Leukocytes; Lung; Maleimides; Mice; Positron-Emission Tomography; Pulmonary Fibrosis; Staining and Labeling; Tomography, X-Ray Computed | 2015 |
FDG-PET/CT in the prediction of pulmonary function improvement in nonspecific interstitial pneumonia. A Pilot Study.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Forced Expiratory Volume; Forecasting; Humans; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Pulmonary Fibrosis; Radiographic Image Enhancement; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Total Lung Capacity; Treatment Outcome; Vital Capacity | 2016 |
Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Male; Pilot Projects; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2009 |
A 41-year-old man with fluorodeoxyglucose-avid thickening on PET scan.
Topics: Adult; Chronic Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Pleurisy; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals; Spondylitis, Ankylosing | 2010 |
Radiological changes after stereotactic radiotherapy for stage I lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Pulmonary Fibrosis; Radiation Pneumonitis; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
False-positive FDG-PET and bronchial anthracofibrosis.
Topics: Aged; Anthracosis; Bronchial Diseases; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals | 2012 |
Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Radiopharmaceuticals; Respiratory Function Tests; Sarcoidosis, Pulmonary; Severity of Illness Index; Tomography, X-Ray Computed; Vital Capacity; Young Adult | 2013 |
Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Topics: Aged; Aged, 80 and over; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Fibrosis; Radiation Injuries; Radiosurgery; Recurrence; Tomography, X-Ray Computed | 2013 |
A case of lung cancer associated with pneumoconiosis diagnosed by fluorine-18 fluorodeoxyglucose positron emission tomography.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pneumoconiosis; Pulmonary Fibrosis; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2003 |
Progressive massive fibrosis secondary to pulmonary silicosis appearance on F-18 fluorodeoxyglucose PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals; Silicosis; Tomography, X-Ray Computed | 2004 |
Idiopathic pulmonary fibrosis on F-18 FDG positron emission tomography.
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals; Tongue Neoplasms | 2005 |
[A case of adenocarcinoma of lung with idiopathic pulmonary fibrosis, showing 1 8-fluorodeoxyglucose uptake in positron emission tomograhy].
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Fibrosis | 2005 |
Idiopathic pulmonary fibrosis: evaluation with positron emission tomography.
Topics: Aged; Aged, 80 and over; Biopsy; Carbon Monoxide; Fluorodeoxyglucose F18; Humans; Lung; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Total Lung Capacity | 2006 |
Kaposi sarcoma after bilateral lung transplantation.
Topics: Biopsy; Cystic Fibrosis; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Herpesvirus 8, Human; Humans; Lung; Lung Neoplasms; Lung Transplantation; Male; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Pulmonary Fibrosis; Radiopharmaceuticals; Sarcoma, Kaposi; Tomography, X-Ray Computed | 2008 |
Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
Topics: Carcinoma, Bronchogenic; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pulmonary Fibrosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Pulmonary fibrosis correlates with duration of tissue neutrophil activation.
Topics: Animals; Autoradiography; Complement C5a; Fluorodeoxyglucose F18; Neutrophil Activation; Pulmonary Fibrosis; Rabbits; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 1998 |
Bleomycin-induced alveolitis detected by FDG positron emission tomography.
Topics: Adult; Aged; Bleomycin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Pulmonary Fibrosis; Radiography; Radionuclide Imaging; Radiopharmaceuticals | 2002 |